Global Blood Cancer Therapeutics Market Research Report 2023

Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.

The global Blood Cancer Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Blood Cancer Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Blood Cancer Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Blood Cancer Therapeutics in Cancer Research Centers is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Blood Cancer Therapeutics include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Novartis, Boehringer Ingelheim, Pfizer and Sanofi, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Blood Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Cancer Therapeutics.

The Blood Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Cancer Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Chronic Myeloid Leukemia (CML)

1.2.3 Acute Lymphocytic Leukemia (ALL)

1.2.4 Chronic Lymphocytic Leukemia (CLL)

1.2.5 Acute Myeloid Leukemia (AML)

1.3 Market by Application

1.3.1 Global Blood Cancer Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Cancer Research Centers

1.3.3 Cancer Hospital

1.3.4 Surgical Centers

1.3.5 Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Blood Cancer Therapeutics Market Perspective (2018-2029)

2.2 Blood Cancer Therapeutics Growth Trends by Region

2.2.1 Global Blood Cancer Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Blood Cancer Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Blood Cancer Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Blood Cancer Therapeutics Market Dynamics

2.3.1 Blood Cancer Therapeutics Industry Trends

2.3.2 Blood Cancer Therapeutics Market Drivers

2.3.3 Blood Cancer Therapeutics Market Challenges

2.3.4 Blood Cancer Therapeutics Market Restraints

3.1 Global Top Blood Cancer Therapeutics Players by Revenue

3.1.1 Global Top Blood Cancer Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Blood Cancer Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Blood Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Blood Cancer Therapeutics Revenue

3.4 Global Blood Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Blood Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Cancer Therapeutics Revenue in 2022

3.5 Blood Cancer Therapeutics Key Players Head office and Area Served

3.6 Key Players Blood Cancer Therapeutics Product Solution and Service

3.7 Date of Enter into Blood Cancer Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Blood Cancer Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Blood Cancer Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Blood Cancer Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Blood Cancer Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Blood Cancer Therapeutics Market Size (2018-2029)

6.2 North America Blood Cancer Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Blood Cancer Therapeutics Market Size by Country (2018-2023)

6.4 North America Blood Cancer Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Blood Cancer Therapeutics Market Size (2018-2029)

7.2 Europe Blood Cancer Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Blood Cancer Therapeutics Market Size by Country (2018-2023)

7.4 Europe Blood Cancer Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Blood Cancer Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Blood Cancer Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Blood Cancer Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Blood Cancer Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Blood Cancer Therapeutics Market Size (2018-2029)

9.2 Latin America Blood Cancer Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Blood Cancer Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Blood Cancer Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Blood Cancer Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Blood Cancer Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Blood Cancer Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Blood Cancer Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Blood Cancer Therapeutics Introduction

11.1.4 AbbVie Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.1.5 AbbVie Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Detail

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Blood Cancer Therapeutics Introduction

11.2.4 AstraZeneca Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.2.5 AstraZeneca Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Detail

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Introduction

11.3.4 Bristol-Myers Squibb Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Detail

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Blood Cancer Therapeutics Introduction

11.4.4 GlaxoSmithKline Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.4.5 GlaxoSmithKline Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Blood Cancer Therapeutics Introduction

11.5.4 Roche Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.5.5 Roche Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Blood Cancer Therapeutics Introduction

11.6.4 Novartis Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.6.5 Novartis Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Detail

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Introduction

11.7.4 Boehringer Ingelheim Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Blood Cancer Therapeutics Introduction

11.8.4 Pfizer Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.8.5 Pfizer Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Blood Cancer Therapeutics Introduction

11.9.4 Sanofi Revenue in Blood Cancer Therapeutics Business (2018-2023)

11.9.5 Sanofi Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Blood Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Chronic Myeloid Leukemia (CML)

    Table 3. Key Players of Acute Lymphocytic Leukemia (ALL)

    Table 4. Key Players of Chronic Lymphocytic Leukemia (CLL)

    Table 5. Key Players of Acute Myeloid Leukemia (AML)

    Table 6. Global Blood Cancer Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Blood Cancer Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Blood Cancer Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Blood Cancer Therapeutics Market Share by Region (2018-2023)

    Table 10. Global Blood Cancer Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Blood Cancer Therapeutics Market Share by Region (2024-2029)

    Table 12. Blood Cancer Therapeutics Market Trends

    Table 13. Blood Cancer Therapeutics Market Drivers

    Table 14. Blood Cancer Therapeutics Market Challenges

    Table 15. Blood Cancer Therapeutics Market Restraints

    Table 16. Global Blood Cancer Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Blood Cancer Therapeutics Market Share by Players (2018-2023)

    Table 18. Global Top Blood Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Therapeutics as of 2022)

    Table 19. Ranking of Global Top Blood Cancer Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Blood Cancer Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Blood Cancer Therapeutics Product Solution and Service

    Table 23. Date of Enter into Blood Cancer Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Blood Cancer Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Blood Cancer Therapeutics Revenue Market Share by Type (2018-2023)

    Table 27. Global Blood Cancer Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Blood Cancer Therapeutics Revenue Market Share by Type (2024-2029)

    Table 29. Global Blood Cancer Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Blood Cancer Therapeutics Revenue Market Share by Application (2018-2023)

    Table 31. Global Blood Cancer Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Blood Cancer Therapeutics Revenue Market Share by Application (2024-2029)

    Table 33. North America Blood Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Blood Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Blood Cancer Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Blood Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Blood Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Blood Cancer Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Blood Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Blood Cancer Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Blood Cancer Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Blood Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Blood Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Blood Cancer Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Blood Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Blood Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Blood Cancer Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. AbbVie Company Detail

    Table 49. AbbVie Business Overview

    Table 50. AbbVie Blood Cancer Therapeutics Product

    Table 51. AbbVie Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 52. AbbVie Recent Development

    Table 53. AstraZeneca Company Detail

    Table 54. AstraZeneca Business Overview

    Table 55. AstraZeneca Blood Cancer Therapeutics Product

    Table 56. AstraZeneca Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 57. AstraZeneca Recent Development

    Table 58. Bristol-Myers Squibb Company Detail

    Table 59. Bristol-Myers Squibb Business Overview

    Table 60. Bristol-Myers Squibb Blood Cancer Therapeutics Product

    Table 61. Bristol-Myers Squibb Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 62. Bristol-Myers Squibb Recent Development

    Table 63. GlaxoSmithKline Company Detail

    Table 64. GlaxoSmithKline Business Overview

    Table 65. GlaxoSmithKline Blood Cancer Therapeutics Product

    Table 66. GlaxoSmithKline Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 67. GlaxoSmithKline Recent Development

    Table 68. Roche Company Detail

    Table 69. Roche Business Overview

    Table 70. Roche Blood Cancer Therapeutics Product

    Table 71. Roche Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 72. Roche Recent Development

    Table 73. Novartis Company Detail

    Table 74. Novartis Business Overview

    Table 75. Novartis Blood Cancer Therapeutics Product

    Table 76. Novartis Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 77. Novartis Recent Development

    Table 78. Boehringer Ingelheim Company Detail

    Table 79. Boehringer Ingelheim Business Overview

    Table 80. Boehringer Ingelheim Blood Cancer Therapeutics Product

    Table 81. Boehringer Ingelheim Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 82. Boehringer Ingelheim Recent Development

    Table 83. Pfizer Company Detail

    Table 84. Pfizer Business Overview

    Table 85. Pfizer Blood Cancer Therapeutics Product

    Table 86. Pfizer Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 87. Pfizer Recent Development

    Table 88. Sanofi Company Detail

    Table 89. Sanofi Business Overview

    Table 90. Sanofi Blood Cancer Therapeutics Product

    Table 91. Sanofi Revenue in Blood Cancer Therapeutics Business (2018-2023) & (US$ Million)

    Table 92. Sanofi Recent Development

    Table 93. Research Programs/Design for This Report

    Table 94. Key Data Information from Secondary Sources

    Table 95. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Blood Cancer Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Blood Cancer Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Chronic Myeloid Leukemia (CML) Features

    Figure 4. Acute Lymphocytic Leukemia (ALL) Features

    Figure 5. Chronic Lymphocytic Leukemia (CLL) Features

    Figure 6. Acute Myeloid Leukemia (AML) Features

    Figure 7. Global Blood Cancer Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Blood Cancer Therapeutics Market Share by Application: 2022 VS 2029

    Figure 9. Cancer Research Centers Case Studies

    Figure 10. Cancer Hospital Case Studies

    Figure 11. Surgical Centers Case Studies

    Figure 12. Clinics Case Studies

    Figure 13. Blood Cancer Therapeutics Report Years Considered

    Figure 14. Global Blood Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Blood Cancer Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Blood Cancer Therapeutics Market Share by Region: 2022 VS 2029

    Figure 17. Global Blood Cancer Therapeutics Market Share by Players in 2022

    Figure 18. Global Top Blood Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Therapeutics as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Blood Cancer Therapeutics Revenue in 2022

    Figure 20. North America Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Blood Cancer Therapeutics Market Share by Country (2018-2029)

    Figure 22. United States Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Blood Cancer Therapeutics Market Share by Country (2018-2029)

    Figure 26. Germany Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Blood Cancer Therapeutics Market Share by Region (2018-2029)

    Figure 34. China Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Blood Cancer Therapeutics Market Share by Country (2018-2029)

    Figure 42. Mexico Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Blood Cancer Therapeutics Market Share by Country (2018-2029)

    Figure 46. Turkey Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Blood Cancer Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. AbbVie Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 49. AstraZeneca Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 51. GlaxoSmithKline Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 52. Roche Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 53. Novartis Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 54. Boehringer Ingelheim Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 55. Pfizer Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 56. Sanofi Revenue Growth Rate in Blood Cancer Therapeutics Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed